NCT01694264: Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα |
|
|
| Terminated | 3 | 43 | RoW | Entecavir, Baraclude (Bristol-Myers Squibb) 0.5mg, Placebo, placebo, prepared by Bristol-Myers Squibb | Seoul National University Hospital, Konkuk University Medical Center, Kyungpook National University Hospital, Kyunghee University Medical Center, Kyung Hee University Hospital at Gangdong, Gachon University Gil Medical Center, Daegu Catholic University Medical Center, Eulji University Hospital, SMG-SNU Boramae Medical Center, The Catholic University of Korea, Severance Hospital, Ajou University School of Medicine, Ewha Womans University Mokdong Hospital, Inha University Hospital, Chonnam National University Hospital, Chonbuk National University Hospital, Chungnam National University Hospital, Hallym University Medical Center, Hanyang University, Dong-A University, Korea University Guro Hospital | Chronic Hepatitis B, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis, Juvenile Idiopathic Arthritis | 08/15 | 12/15 | | |
